Brighton Jones LLC Has $1.39 Million Stake in HCA Healthcare, Inc. $HCA

Brighton Jones LLC boosted its position in HCA Healthcare, Inc. (NYSE:HCA) by 5.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,636 shares of the company’s stock after buying an additional 178 shares during the period. Brighton Jones LLC’s holdings in HCA Healthcare were worth $1,393,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Cheviot Value Management LLC acquired a new position in HCA Healthcare in the first quarter valued at $26,000. Saudi Central Bank bought a new stake in HCA Healthcare in the first quarter valued at $26,000. WPG Advisers LLC bought a new stake in HCA Healthcare in the first quarter valued at $27,000. Ameriflex Group Inc. bought a new stake in HCA Healthcare in the second quarter valued at $27,000. Finally, Chung Wu Investment Group LLC bought a new stake in HCA Healthcare in the second quarter valued at $27,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

HCA has been the subject of several research analyst reports. Sanford C. Bernstein reaffirmed a “market perform” rating and issued a $417.00 price target on shares of HCA Healthcare in a research note on Monday. Raymond James Financial set a $525.00 target price on shares of HCA Healthcare in a research report on Monday. JPMorgan Chase & Co. boosted their target price on shares of HCA Healthcare from $360.00 to $370.00 and gave the stock a “neutral” rating in a research report on Monday, August 4th. Barclays boosted their target price on shares of HCA Healthcare from $445.00 to $494.00 and gave the stock an “overweight” rating in a research report on Monday. Finally, UBS Group boosted their target price on shares of HCA Healthcare from $495.00 to $525.00 and gave the stock a “buy” rating in a research report on Monday. Thirteen equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $471.42.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $468.68 on Tuesday. The stock has a market cap of $109.67 billion, a PE ratio of 18.12, a price-to-earnings-growth ratio of 1.41 and a beta of 1.40. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $469.18. The firm’s 50-day simple moving average is $416.33 and its 200 day simple moving average is $383.23.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. The firm had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company’s quarterly revenue was up 9.6% on a year-over-year basis. During the same period in the previous year, the company earned $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s payout ratio is presently 11.13%.

Insiders Place Their Bets

In related news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 1.30% of the stock is currently owned by insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.